These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 18567278
1. GnRH agonist long protocol vs. a single 3-mg gnRH antagonist: a comparison of 2 protocols for pituitary down-regulation in oocyte donor-controlled ovarian hyperstimulation cycles. Erb TM, Wakim AN. J Reprod Med; 2008 May; 53(5):331-7. PubMed ID: 18567278 [Abstract] [Full Text] [Related]
2. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles. Wei AY, Mijal KA, Christianson MS, Schouweiler CM, Lindheim SR. J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715 [Abstract] [Full Text] [Related]
7. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer. Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH. Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845 [Abstract] [Full Text] [Related]
9. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C. Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261 [Abstract] [Full Text] [Related]
10. [Comparison of GnRH agonists and antagonists in an ovular donation program]. Saucedo de la Llata E, Moraga Sánchez MR, Batiza Reséndiz V, Santos Haliscak R, Galache Vega P, Hernández Ayup S. Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901 [Abstract] [Full Text] [Related]
11. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle. Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H. Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238 [Abstract] [Full Text] [Related]
12. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles. Rashid MR, Ong FB, Omar MH, Ng SP, Nurshaireen A, Sharifah-Teh NS, Fazilah AH, Zamzarina MA. Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295 [Abstract] [Full Text] [Related]
14. [Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response]. Wang B, Sun HX, Hu YL, Chen H, Zhang NY. Zhonghua Nan Ke Xue; 2008 May; 14(5):423-6. PubMed ID: 18572861 [Abstract] [Full Text] [Related]